跳至主要内容
临床试验/TCTR20220310008
TCTR20220310008进行中(未招募)4 期

Comparison of the efficacy of tadalafil in the treatment of erectile dysfunction of patients under hemodialysis or kidney transplants

rology-Nephrology Research Center of Shahid Beheshti University of Medical Sciences0 个研究点目标入组 45 人开始时间: 2022年3月10日最近更新:
适应症

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
Male

入选标准

  • 1. End stage renal disease with any kind of renal replacement therapy (haemodialysis or kidney transplantation), 2. Erectile dysfunction

排除标准

  • 1. Cognitive impairment, 2. Communication impairment, 3. Genital anatomical deformity, 4. Time from last transplant of less than 6 months, 5. Taking drugs causing erectile dysfunction (e.g. beta-blockers, tricyclic antidepressants), 6. Taking nitrate derivatives and nitric oxide donors, 7. Not prepared to discontinue other erectile dysfunction treatments in the coarse of the study

研究者

发起方
rology-Nephrology Research Center of Shahid Beheshti University of Medical Sciences

相似试验

The effect of tadalafil in the treatment of erectile... | 临床试验